// App-Quantinova.ai

P5.335 : Myelin water imaging provides evidence of long-term remyelination and neuroprotection in Alemtuzumab treated multiple sclerosis patients (P5.335)

Researchers

Presenter

  • Irene Vavasour

Principal Investigators

  • Cornelia Laule

  • Shannon Kolind

  • Roger Tam

  • David Li

  • Alex MacKay

  • Anthony Traboulsee

Medical Centers

  • The University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Alemtuzumab

  • Interferon

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A